Clinical trial

Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery

NCT00058357 · Alliance for Clinical Trials in Oncology, Other · Completed

Key facts

NCT number NCT00058357
Title Lidocaine Patch in Treating Cancer Patients With Neuropathic Pain After Surgery
Official title The Efficacy Of Lidocaine Patch In The Management Of Postsurgical Neuropathic Pain In Patients With Cancer: A Phase III Double-Blind, Crossover Study
Lead sponsor Alliance for Clinical Trials in Oncology, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Pain, Unspecified Adult Solid Tumor, Protocol Specific
Intervention type Drug, Other
Interventions lidocaine, placebo
Enrollment 30
Start date May 1, 2004
Primary completion Jul 1, 2006
Completion Jul 1, 2007
First posted Apr 9, 2003
Last update posted Jun 28, 2016
Countries United States

At a glance

  • 100–999 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies